Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1

计划入组 65 人 · 首次发布于 2025 年 6 月 17 日

CRF1 Antagonist GSK561679 in Alcoholism

计划入组 44 人 · 首次发布于 2010 年 8 月 24 日

A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

计划入组 250 人 · 首次发布于 2016 年 9 月 23 日

NRF1 gene transcriptional regulators (Infixion Bioscience)

NRF1 targeted antisense oligonucleotides (Infixion Bioscience)

NR11/1943

St. Jude Scientists Discover How to Restore Dendritic Cell Function to Enhance Cancer Immunotherapy

Six Taipei Biotechs Head to BIO 2026 with Late-Stage Assets, Precision Diagnostics, and Next-Generation Drug Delivery Platforms

FDA Extends Review of Merus' Zenocutuzumab for NRG1+ Cancers